Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations.

Rouhani, S. J., Hadfield, M. J., Lei, M., Merkin, R. D., Dougan, M., Hobbs, G. S., Hammond, S. P., & Reynolds, K. L. (2026). Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations.. Current Oncology Reports, 28(1), 12.